IPO ChampIPO Insights
IPO Champ LogoIPO Champ Logo

IPOs

IPO Calendar
GMP Tracker
Subscription Status
Allotment Status
Stock Broker
  • Follow us on Instagram
  • Follow us on Facebook
  • Follow us on Threads
  • Follow us on YouTube
  • Follow us on Telegram
  • Follow us on WhatsApp
HomeIPOTarsier Pharma Ltd.

About

Tarsier Pharma Ltd.

Tarsier Pharma is a late clinical stage biopharmaceutical company, focused on the development and commercialization of novel pharmaceutical therapies to address unmet need in blinding diseases of the eye with underlying inflammatory pathologies.

Our dazdotuftide platform technology is a bio-inspired immunomodulator, designed to treat blinding inflammatory ocular diseases, and is currently being developed as both eye drops (TRS01) and intravitreal injections (TRS02).

The data for this page was gathered manually by the Stock Analysis team, from official company filings available on SEC.gov.

Tarsier Pharma Ltd. Overview

Ticker, listing venue and issuer profile

TickerTARX
ExchangeNYSE
Statusupcoming
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CIK Code2102720
CUSIP--
ISINIL0012414889

Offer & Key Dates

Pricing terms and IPO milestones

Price Range$8.00 - $10.00
Offer Price--
Listing Price--
Current Price--
Shares Offered5M
Shares Outstanding28.74M
Offer Size$45.00M
Market Cap$258.63M
Filing Date--
Priced Date--
Listed DateJul 15, 2026

Valuation & Multiples

Key valuation ratios and metrics

P / E--
P / Book--
P / Sales--
EV / EBITDA--
EPS--
Revenue / Share (TTM)--
Revenue$0.00
Net Income-$5.07M

Financial Health

Balance sheet strength and liquidity

Total Debt$6.62M
Total Assets$2.33M
Cash$2.00M
Free Cash Flow--
Current Ratio2.48
Quick Ratio2.48
Debt / Equity--
CapEx--

Profitability & Returns

Margins and return on capital

Gross Margin--
Operating Margin--
Net Margin--
Return on Equity--
Return on Assets-280.73%
ROIC-452.88%
EBITDA--
Gross Profit-$5.00K

Financial Highlights

Historical financial performance

SEC Filings

Official documents from SEC EDGAR

FormFiling DateDocument
F-1/AJun 16, 2026[Amend] Registration statement for certain foreign private issuers
F-1/AJun 8, 2026[Amend] Registration statement for certain foreign private issuers
FWPMay 18, 2026Free Writing Prospectus
F-1/AMay 18, 2026[Amend] Registration statement for certain foreign private issuers
F-1Apr 21, 2026Registration statement for certain foreign private issuers
DRS/AMar 31, 2026[Amend] [Cover] Draft Registration Statement
DRS/AFeb 24, 2026[Amend] [Cover] Draft Registration Statement
DRSDec 29, 2025[Cover] Draft Registration Statement

Company Info

Contact and headquarters details

Websitehttps://tarsierpharma.com/
HeadquartersIsrael
Founded2016
Employees3
Phone+972-4-639-8050
Address10 HaMa’apilim St.Zichron Yaacov, 3093765Israel

Leadership

Key executives and officers

DH

Daphne Haim-Langford, Ph.D.

Chief Executive Officer and Chairperson of the Board

AG

Arie Ganot, CPA

Chief Financial Officer

ZM

Zohar Milman, M.Sc.

Chief Operating Officer

RN

Ron Neumann, M.D.

Chief Medical Officer

SB

Susan Benton

Director

SB

Sascha Bucher

Director

AR

Atul Raut

Director

Tarsier Pharma Ltd. IPO - FAQs

IPO (initial public offering) is the process through which a private company offers its shares to the public for the first time to raise equity capital from a broader base of public investors.











Quick Facts

Exchange
NYSE
Ticker
TARX
Deal Type
IPO
Offer Size
$45.00M
Market Cap
$258.63M
Shares Offered
5M

Company Info

Website
https://tarsierpharma.com/
Headquarters
Israel
Founded
2016
Employees
3
Phone
+972-4-639-8050
Address
10 HaMa’apilim St.Zichron Yaacov, 3093765Israel
IPO Champ LogoIPO Champ Logo

IPO Champ helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

Tools

IPO CalendarGMP TrackerSubscription StatusAllotment Status

IPOs

All IPOsLive IPOsUpcoming IPOsClosed IPOsListed IPOs

Resources

NewseBooks

Company

HomeAbout UsPrivacy PolicyTerms of Service

About IPO Champ

IPO Champ is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@ipochamp.com.

Please read all offer documents and risk disclosures carefully before investing. IPO Champ does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Champ. All rights reserved.

Want to stay updated?Subscribe to our newsletter

Tarsier Pharma Ltd.

Tarsier Pharma Ltd.

TARXNYSE
upcoming

Issue Size

$45.00M

Price Range

$8.00 - $10.00

Shares

28.74M o/s · 5M offered

Probable listing

Jul 15, 2026

Sector

Healthcare